US Patent

US7806265 — Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application

Formulation · Assigned to Mobius Therapeutics LLC · Expires 2029-02-01 · 3y remaining

Vulnerability score 43/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects an apparatus for reconstituting a pharmaceutical, specifically an ophthalmic formulation of mitomycin-C, for transient application.

USPTO Abstract

An apparatus for preparing a pharmaceutical for transient application includes a tray having a sealed compartment, a vial of an ophthalmic formulation of mitomycin-C, a diluent carrier containing sterilized water, and a syringe that are all contained together in a single package. The component parts of the apparatus are used together to reconstitute the contents of the vial with the water in the diluent carrier, and then draw the reconstituted drug into the sealed compartment of the tray by a suction force produced by the syringe. In the tray compartment, the reconstituted drug is absorbed in an absorbent pad. The tray is opened to remove the pad and the absorbed drug from the tray compartment for use of the pad in transient application of the drug.

Drugs covered by this patent

Patent Metadata

Patent number
US7806265
Jurisdiction
US
Classification
Formulation
Expires
2029-02-01
Drug substance claim
No
Drug product claim
Yes
Assignee
Mobius Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.